Onyx Biotec Ltd (ONYX) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Onyx Biotec Ltd on NSE and BSE, with an AI summary of each filing.
VC Corporate Advisors Private Limited has Submitted to the Exchange a copy of offer opening public announcement cum corrigendum to the detailed public statement to the public shareholders of the Onyx Biotec Limited (Target Company).
Others (Uncategorized) · 14 Oct 2026, 10:41 pm
Onyx Biotec Limited has informed regarding Submission of the Non-Applicability of the provisions relating to Corporate Governance as specified in the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.
Others (Uncategorized) · 14 Oct 2026, 12:25 am
Onyx Biotec Confirms Non-Applicability of SEBI Corporate Governance Provisions Onyx Biotec Limited informed the NSE that corporate governance provisions under Regulation 15 of SEBI (LODR) Regulations, 2015, do not apply to the company for the quarter ended 30th Sep'26. The exemption applies as the company's specified securities are listed on the NSE EMERGE SME platform. Consequently, specified governance mandates under regulations 17 through 27, regulation 46(2) clauses (b) to (i) and (t), and Schedule V paras C, D, and E remain non-applicable.
Onyx Biotec Limited has Submitted to the Exchange a newspaper copy of the Recommendation of the Independent Director Committee ("IDC") of the company in relation to the Open Offer made by Mr. Kunal Bhardwaj ( Acquirer 1 ), Mr. Gautam Bhardwaj ( Acquirer 2 ), Mr. Kanhaiya Bhardwaj ( Acquirer 3 ) and Mr. Kapil Bhardwaj ( Acquirer 4 ) (hereinafter collectively referred to as the Acquirers ) to the public shareholders of the company under Regulation 26(7) of SEBI (SAST) Regulations, 2011 and subseq
Others (Uncategorized) · 08 Oct 2026, 10:08 pm
Onyx Biotec Committee of Independent Directors Recommends Open Offer Onyx Biotec Limited announced that its Committee of Independent Directors (IDC) published its recommendations on 8th Oct'26 regarding the open offer by Kunal Bhardwaj, Gautam Bhardwaj, Kanhaiya Bhardwaj, and Kapil Bhardwaj. The acquirers offered to acquire up to 47,14,372 equity shares (26.00% of voting share capital) of face value Rs. 10 each. Based on the valuation report by independent valuer Brijesh Kumar confirming a fair value of Rs. 34.51 per share, the IDC recommended the offer price of Rs. 36.50 per share as fair and reasonable.
Onyx Biotec Limited has Submitted to the Exchange the outcome of the meeting of the committee of the Independent Directors held today i.e. October 07, 2026 to give their recomendation in the Open Offer of Onyx Biotec Limited in compliance with Regulation 26(7) of the SEBI (SAST) Regulations, 2011and subsequent Amendments thereto.
Others (Uncategorized) · 08 Oct 2026, 12:09 am
Onyx Biotec Independent Directors Review Open Offer for 26% Equity Stake The Committee of Independent Directors of Onyx Biotec Limited met on 7th Oct'26 to review the open offer launched by Kunal Bhardwaj, Gautam Bhardwaj, Kanhaiya Bhardwaj, and Kapil Bhardwaj. The acquirers propose to acquire up to 47,14,372 equity shares (Rs 10 face value), representing 26.00% of the company's total voting equity share capital under SEBI SAST Regulations. The committee's formal recommendations will be submitted to SEBI, NSE, and manager VC Corporate Advisors, and published in newspapers following the 31st Jul'26 Detailed Public Statement.
VC Corporate Advisors Private Limited has Submitted to the Exchange a copy of Letter of Offer.
Others (Uncategorized) · 07 Oct 2026, 4:51 pm
Onyx Biotec Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 28, 2026. Further, the company has informed the Exchange regarding voting results.
Annual General Meeting · 29 Sept 2026, 12:10 am
Onyx Biotec Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 28, 2026
Annual General Meeting · 29 Sept 2026, 12:06 am
Onyx Biotec Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 28, 2026
Annual General Meeting · 05 Sept 2026, 9:59 pm
Onyx Biotec Limited has informed the Exchange regarding Outcome of Board Meeting held on September 03, 2026.
Outcome · 03 Sept 2026, 10:29 pm
Onyx Biotec Board Redesignates Naresh Kumar as MD and Sets AGM Dates Onyx Biotec Ltd. announced key board decisions on 3rd Sep'26, highlighted by the redesignation of Mr. Naresh Kumar from Whole-Time Director to Managing Director, pending shareholder approval. The board scheduled the 21st AGM for 28th Sep'26 via video conferencing. For the AGM, the e-voting cut-off date is set for 21st Sep'26, with book closure running from 22nd Sep'26 to 28th Sep'26. Additionally, M/s. K.K. Sinha & Associates was appointed as Cost Auditor, and M/s. M Shahnawaz & Associates was named scrutinizer.
VC Corporate Advisors Private Limited has Submitted to the Exchange a copy of corrigendum to the public announcement dated July24, 2026 for the attention of the public shareholders of the Onyx Biotec Limited.
Others (Uncategorized) · 04 Aug 2026, 4:25 pm
VC Corporate Advisors Pvt Ltd has submitted to the Exchange a copy of Detailed public statement in terms of Regulations 3(1) & 4 Read with Regulation 15(2) of the SEBI (SAST) Regulations, 2011, as amended for the attention of the Public shareholders of the company.
Others (Uncategorized) · 01 Aug 2026, 1:00 am
Onyx Biotec Acquirers Launch Open Offer for 26% Stake Four acquirers, led by Mr. Kunal Bhardwaj, launched an open offer on 31 Jul'26 to acquire up to 47,14,372 equity shares (26.00%) of Onyx Biotec Limited. This was triggered by a Share Purchase Agreement on 24 Jul'26 to buy 32,18,200 shares (17.75%) from promoters. Following the purchase, the acquirers' aggregate shareholding will rise to 39.04%, necessitating the mandatory open offer under SEBI SAST Regulations. The offer is for public shareholders of the NSE Emerge-listed company.
VC Corporate Advisors Pvt Ltd has submitted to the Exchange a copy of Public announcement under Regulations 3(1) and 4 Read with Regulations 13, 14 and 15 of the SEBI (SAST) Regulations, 2011 ("SEBI SAST Regulations") for the attention of the Equity shareholders of the company.
Others (Uncategorized) · 25 Jul 2026, 12:15 am
Onyx Biotec Limited has informed regarding Submission of the Compliance Report on Non-Applicability of the provisions relating to Corporate Governance as specified in the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.
Others (Uncategorized) · 08 Jul 2026, 6:31 pm
Onyx Biotec Claims Exemption from SEBI Corporate Governance Norms Onyx Biotec Ltd. informed the exchange on 8 Jul'26 that Corporate Governance provisions under SEBI (LODR) Regulations, 2015 are not applicable for the quarter ended 30 Jun'26. The exemption applies as the company has listed its securities on the NSE EMERGE platform. SEBI regulations grant this exemption to companies with paid-up equity capital not exceeding ₹10 Crore and net worth under ₹25 Crore, or those listed on SME exchanges. This significantly reduces the company's compliance and disclosure requirements.